March 2012

Xavier Bosch, Lilly Biomedical Research Award 2012

The researcher Xavier Bosch, head of the group on Viruses and Cancer at IDIBELL and Director of the Research in Cancer Epidemiology program at the Catalan Institute of Oncology (ICO), has been awarded the Lilly Foundation for Biomedical Research award 2012 in the category preclinical research. The Lilly Foundation has highlighted the contribution of Xavier […]

Xavier Bosch, Lilly Biomedical Research Award 2012 Read More »

Nature Biotech calls ”signal of a new era in biomedical research” the BLUEPRINT project

Nature Biotech publishes in its latest issue an article about the European project Blueprint that was launched last October and aims to generate epigenomic maps of up to one hundred different types of blood cells to help researchers understand how the epigenome influences health and disease. The Cancer Epigenetics and Biology Program of IDIBELL, led

Nature Biotech calls ”signal of a new era in biomedical research” the BLUEPRINT project Read More »

Peter Ten Dijke: “TGF-beta receptors may be therapeutic targets in treatments to prevent metastasis

The study of the molecular mechanisms that regulate the signaling pathways of transforming growth factor (TGF-beta) is the field of action of Peter Ten Djike and his research group at the University of Leiden, the Netherlands. Ten Djike explained their latest developments in a lecture in the seminar series IDIBELL on March 2. TGF-beta is

Peter Ten Dijke: “TGF-beta receptors may be therapeutic targets in treatments to prevent metastasis Read More »

IDIBELL participates in a European project to detect and prevent type 2 diabetes

Researchers of the Epigenetics and Cancer Biology program at IDIBELL, led by Manel Esteller, participate in the European project DEXLIFE that aims research new ways to detect and prevent type 2 diabetes. The project funded with 5.5 million euros by the European Union within the 7th Framework Programme for Research and Development will take place

IDIBELL participates in a European project to detect and prevent type 2 diabetes Read More »

The loss of a protein makes ‘jump’ the tumor to the lymph node

Metastasis is responsible for 90% of deaths in patients with cancer. So understand the mechanisms responsible for this process are one of the top goals of cancer research. The metastatic process involves a series of steps chained where the primary tumor invades surrounding tissue and ends spreading throughout the body. One of the first tissues

The loss of a protein makes ‘jump’ the tumor to the lymph node Read More »

IDIBELL launches ‘Caenorhabditis elegans’ Facility

C. elegans is a nematode that measures millimetre of length, approximately. It has been used to study the genetics of development and the nervous system, and in recent years is making contributions to the study of aging, cell death and genome structure. In 1998 it has been published the complete sequence of its genome, comprising

IDIBELL launches ‘Caenorhabditis elegans’ Facility Read More »

Scroll to Top